A legal roadmap for Cannabis

International
06/12/2019
Download PDF

In recent years cannabis trade and related activity has developed into a growth business area. In the life sciences and healthcare fields there have been increases in the numbers of patients having access to medicinal cannabis and more general acceptance of the potential medicinal value of cannabis for patients. The number of countries allowing its recreational use has increased. Additionally, there is growing awareness of the potential for and actual use of cannabis plants across a range of different industry sectors, not least in cosmetics and food.

Taking account of the evolving political and ethical implications of cannabis production, trade and use it is important to be aware of differences in approach across different countries to assess which businesses and activities are viable in 21 different (EU and non-EU) jurisdictions.

This guide provides high level information about the legal approach to regulating cannabis across a variety of jurisdictions in different regions. In each case the guide focuses on (i) medical use; (ii) recreational use; (iii) industrial use and (iv) the patentability of cannabis-based products.

For more information on this developing area in the sectors of life sciences and healthcare and consumer products, contact your regular CMS source or one of the following local CMS experts: Laura Opilio, Ellen Gielen, Shuna Mason.

Search Filters

Advanced Search

Key contacts

Related content